Jiangxi Qingfeng Pharmaceutical Co. Ltd.
32
2
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 32 trials
100.0%
+13.5% vs industry average
25%
8 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal Epilepsy
Role: lead
Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension
Role: lead
Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects
Role: lead
Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data
Role: lead
Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza
Role: lead
Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
Role: lead
GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers
Role: lead
To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection
Role: lead
A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers
Role: lead
A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza
Role: lead
A Phase I Mass Balance Study of [14C]GP681 in Healthy Chinese Male Volunteers
Role: lead
Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in Children
Role: lead
A Phase I Study of BR790 in Subjects With Advanced Solid Tumors
Role: lead
Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer
Role: lead
A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy
Role: lead
Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects
Role: lead
A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients
Role: lead
SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation
Role: lead
Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
Role: lead
Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia
Role: lead